Industry updates with Dusko Ilic: February 2025

Written by Dusko ILIC
Cell therapy Clinical manufacturing Clinical trials FDA Gene therapy Industry developments iPSCs Opinion Regulation & policy Report Stem cells

Read highlights from the February installment of Dusko Ilic’s industry news, which discusses the latest developments and news in regenerative medicine and stem cell research, and is published every month in Regenerative Medicine. What happened this month that you were expecting? FDA greenlights pig kidney xenotransplants The recent US Food and Drug Administration (MD, USA) approval for clinical trials using genetically modified pig kidneys for human transplantation marks a groundbreaking advancement in medicine. United Therapeutics (MD, USA) and eGenesis (MA, USA) will lead these trials. United Therapeutics’ pigs have undergone 10 gene edits to improve compatibility, while eGenesis’ pigs have...

To view this content, please register now for access

It's completely free